way obstruction. In 1967, Macklem and Mead 3 divided airway resistance between central and peripheral components. Following the morphologic characterization of small airways disease, 4,5 many publications reported reference values not only for FVC, FEV 1 , and FEV 1 /VC, but also for FEF . 6 -14 In 1972, a publication entitled, "A Reduction in Maximum Mid-Expiratory Flow Rate: A Spirometric Manifestation of Small-Airways Disease," 15 without giving FEV 1 /FVC data, described the conditions of 53 symptomatic smokers as abnormal because their FEF values were Ͻ 80% of the mean predicted values. The common practice of reporting spirometric values as a percent of predicted values with highlighting of values Ͻ 80% of predicted added confusion. Despite evidence of high variability of FEF values and expert opinion recommending the use of statistically derived 95% confidence limits for the lower limit of normal (LLN) 14,16 -20 small airways disease continued to be diagnosed if FEF values were Ͻ 75 to 80% of mean percentage of predicted values, and FEV 1 or FEV 1 /FVC were Ͼ 75 to 80% of the mean percentage of predicted values. 21 In 1981 and 1985, respectively, Crapo et al 22 and Miller et al 23 published reference equations for white adults that included forced expiratory volume in 3 s (FEV 3 ) and FEV 3 /FVC ratio values. Despite this, a recent search of PubMed found 695 citations for "FEF ," far exceeding the 22 citations found for "FEV 3 /FVC."
In the Third National Health and Nutrition Examination Survey (NHANES III), 24 spirometric values for FVC, peak flow, forced expiratory volume in 0.5 s, FEV 1 , FEV 3 , forced expiratory volume in 6 s (FEV 6 ), FEF , flow after 75% of the FVC has been exhaled (FEF 75 ), and duration of FVC in Ͼ 20,000 US residents were collected, using American Thoracic Society (ATS) standards. Using this database, Hankinson et al 25 analyzed and reported the mean and LLN formulas for FEV 1 , FVC, FEV 1 / FVC, FEV 1 /FEV 6 , and FEF , but not for FEV 3 or FEV 3 /FVC in healthy never-smoking white, African-American, and Mexican-American male and female patients from childhood through age 80 years.
Utilizing data from the same NHANES III source, 24 -26 we did the following: (1) calculated the mean and LLN values for FEV 3 /FVC in these never-smoking and currently smoking groups; (2) compared the variability of FEV 1 /FVC, FEV 3 /FVC, and FEF values in never-smokers and current smokers; and (3) assessed changes associated with aging and smoking. We hypothesized that the fraction of the FVC that had not been expired during the first 3 s of the FVC (1 Ϫ FEV 3 /FVC) measures the increase in long-time-constant lung units that is associated with aging and smoking, and thus adding value to the spirometric assessment of airflow limitation. We further hypothesized that FEV 3 /FVC complements FEV 1 /FVC and that both are superior to FEF in identifying and characterizing expiratory airway obstruction.
Materials and Methods

Subjects
Data from NHANES III 24 were extracted for men and women Ն 20 years of age for the following ethnic-racial groups: white (white); African-American (black); and Mexican-American (Latin or Latina). These data, from unidentified subjects, had been ethically obtained with Institutional Review Board approval. The term never-smokers included individuals those who had not smoked pipes, cigars, or Ͼ 100 cigarettes in a lifetime, and excluded those with known respiratory, skeletal, or neurologic disorders. The term current smokers included all currently smoking adults without known skeletal or neuromuscular disorders. All spirometric tests met ATS standards with at least three reproducible forced expirations and maximal scores for quality and reproducibility. Age was recorded in months, height in 0.1-cm increments, weight in 0.1-kg increments, volumes in milliliters, and flows in milliliters per second.
Calculations
The following calculations were made: (1) the mean, slope, intercept, SE of the estimate, LLN values, and correlation coefficients for FEV 1 /FVC and FEV 3 /FVC were derived by linear regression for black, Latin, and white men and women 20 to 80 years old who had never smoked; (2) the formulas of Hankinson et al 25 and our formulas for FEV 1 /FVC were compared; (3) the LLN as a percentage of the mean predicted values were calculated for FVC, FEV 1, FEV 1 /FVC, FEV 3 /FVC, and FEF for each never-smoking group; (4) for all subjects, deviations from the mean predicted values were plotted, and individuals with values below those for the LLN were identified; and (5) age coefficients for FEV 1 /FVC and 1 Ϫ FEV 3 /FVC were calculated for never-smokers and current smokers.
Pattern Analysis of Current Smokers
We placed each of the currently smoking subjects into 1 of 16 (2 4 ) potential categories, depending on whether or not their FEV 1 , FVC, FEV 1 /FVC, and FEV 3 /FVC values were below the LLN. This allowed us to decide whether each subject had normal spirometry findins, or had a pattern of obstruction, had probable restriction, or a combination, and whether or not the FEF values confirmed the diagnosis or were probably false-positive or false-negative findings.
Statistical Analysis
Except where noted, values are reported as the mean Ϯ SD and the 95th percentile as the LLN.
Results
Several key spirometric values, with respect to ethnicity, gender, age, and height, are provided for the NHANES III never-smokers and current smokers in Table 1 . The number of never-smokers (5,938) differs from that of Hankinson et al 25 because of differences in age ranges and screening procedures. 25 and our formula was only 0.28% for the 5,938 adults that we selected. This reflects the similarity between these two neversmoking series extracted from the same NHANES III database.
Using LLN levels for FEV 1 /FVC, FEV 3 /FVC, and FEF in never-smokers, values of 4.4 to 5.1% were "abnormal" (ie, similar to the expected value of 5.0%). However, if one had improperly considered 80% of the mean predicted FEF value as the LLN, the conditions of an additional 20.8% of never-smoking NHANES III subjects would be considered to be abnormal.
The relative variabilities of five spirometric measures are shown in Figure 1 for the largest group of never-smokers, white women. The LLN as a percentage of the mean predicted value was approximately 94% for FEV 3 /FVC and approximately 88% for FEV 1 /FVC with no significant effect with aging. In contrast, the LLN for FEV 1 , FVC, and FEF decreased from age 20 to 80 years, ranging from 82 to 72% for FEV 1 and FVC, and 67 to 12% for FEF . Similar patterns of variability (not presented) were seen for spirometric measures for all other never-smoking groups. Figure 2 shows marked differences in the variability of FEV 1 /FVC, FEV 3 /FVC, and FEF in never-smokers and current smokers for each fifth percentile of the respective populations when plotted against the percentage of the mean predicted values. The legend emphasizes misclassifications that would result if 80% of mean values was used as the threshold. Figure 3 shows, for each gender of never-smokers and current smokers, the mean first spirometric fractions of forced expiratory maneuvers (ie, FEV 1 / FVC) and last spirometric fractions (ie, 1 Ϫ FEV 3 / FVC). Over this 60-year span for never-smokers, the average FEV 1 /FVC percentage decreases from 85.8 to 74.2%, while the average 1 Ϫ FEV 3 /FVC percentage increases from 2.2 to 12.6%. The absolute changes in FEV 1 /FVC and 1 Ϫ FEV 3 /FVC are nearly similar, whereas the relative changes are much larger for 1 Ϫ FEV 3 /FVC (Fig 3) . There are minimal gender differences and even fewer ethnic differences. Thus, the proportion of flow occurring after the third second, while relatively small at age 20 years, increases markedly in association with older age. The mean fraction of air expelled during the second and third second of forced expiration remains quite stable from ages 20 to 80 years (13 Ϯ 4%). The fact that the correlations of FEV 3 /FVC with age are higher than those for FEV 1 / FVC is noted in the legend of Figure 3 . Importantly, current smokers have further significant decreases in FEV 1 /FVC and increases in 1 Ϫ FEV 3 /FVC (the SE for each point averages Ͻ 0.5%). By middle age, the fractions of FVC for current smokers are equivalent to those of never-smokers who are 20 years older. Table 3 shows the spirometric patterns (normal, expiratory obstruction, possible restriction, combinations, and uncertain) found in individual current smokers and indicates in what groups FEF values might be either confirmatory or suggest inappropriate interpretations. Fewer than 15 smokers (21 of 2,403 smokers) had exclusively abnormal and probably false-positive FEF (line a, Table 3 ). These 12 men and 9 women had average ages of 29 and 35 years, respectively.
Physiologic Defects in Current Smokers
A total of 1,167 (ie, the sum of values from lines b to n, FEF test results tended to be younger. Thus, measurements of FEF , especially in older individuals, often disagree with other spirometric measurements with less inherent variability.
Discussion
This study introduces the concept of the 1 Ϫ FEV 3 /FVC fraction and gives data confirming the utility of the FEV 3 /FVC ratio in assessing expiratory airway obstruction We took advantage of the NHANES III-verified spirometric and demographic data that were available from a large and diverse US population, and expand on the prior excellent analyses of Hankinson et al 25 , and our findings in current smokers confirm our hypothesis that FEF poorly discriminates normal values and those for expiratory obstruction (Fig  1, 2, Table 3 ). In contrast, FEV 3 /FVC correlates even better with age than FEV 1 /FVC and is an excellent measure of late expiratory obstruction (Fig  3, Table 3 ).
Two prior studies 22, 23, 27 have given reference values for FEV 3 /FVC. Each study used 200 to 300 nonsmoking white adults of northern European ethnicity. Over a broad age and height range, our mean FEV 3 /FVC values for white never-smokers are, on average, approximately 1.7% and 1.0% lower than those for men and women reported in the study by Crapo et al 22 and Ͻ 1% lower than those reported in the study by Miller et al. 23, 27 These small differences may relate to resident altitudes, socioeconomic factors, or other unknown factors. 28 Although Miller et al 27 did not emphasize the following information, their data from 359 current smokers showed that FEV 3 /FVC abnormalities exceeded those of FEV 1 / FVC, FEF 50 , FEF , FEV 1 , FEV 3 , FEF 75 , and flow between 75% and 85% of the FVC (FEF 75-85 ) .
In a consensus statement from the National Lung Health Education Program, Ferguson et al 34 reported that 9.6% of the adult (ie, 18 to 89 years of age) NHANES III smokers had an obstructive pattern, which they defined as FEV 1 /FEV 6 and FEV 1 values below the LLN. In our series of 3,570 current smokers, aged 20 to 80 years, a considerably larger percentage (Table 3) showed airflow limitation as manifested by significant decreases in FEV 1 /FVC and FEV 3 /FVC.
In the past, comparatively little attention has been paid to the FEV 3 /FVC or to the fraction of the FVC that had not been expired during the first 3 s of the FVC (ie, 1 Ϫ FEV 3 /FVC). Lower flow rates with aging or disease may be due to both intrinsic airway changes and the loss of lung elastic recoil, promoting increased compression of the airways with forced expiration. 30 -34 In contrast to FEV 1 /FVC, which reflects the reduction in short-time-constant lung units, an increase in 1 Ϫ FEV 3 /FVC assesses the increase in long-time-constant lung units and there- . Individuals are grouped by fifth percentiles above, at, and below mean normal values (using gender, age, height, and ethnicity) of 5,938 individual adult never-smokers from NHANES III data. Values for 3,570 adult current smokers are similarly grouped. In each graph, symbols extend laterally until the incidence is zero. The breadth of the distributions differs markedly, with least for FEV 3 /FVC and the most for FEF . Vertical dashed lines separate those Ͻ 80% of predicted and Ͼ 80% of predicted means, and demonstrate the irrationality of using Ͻ 80% of predicted spirometric parameters to identify abnormal values. Using the 80% criterion, 0.0% of never-smokers and 1.5% of current smokers would have abnormal FEV 3 /FVC values; 0.6% of never-smokers and 7.9% of current smokers would have abnormal FEV 1 fore should be sensitive in detecting developing expiratory flow limitation. With aging and injury, lung units with low elastic recoil and increased airway resistance may proportionally increase. These changes will affect expiratory flow after 3 s (eg, the 1 Ϫ FEV 3 /FVC measurement, which increases proportionately more than the decrease in FEV 1 /FVC (Fig 3) . The very low variability in FEV 3 /FVC in healthy subjects makes for small deviations from the mean predicted values (Fig 1-3) .
In evaluating the cigarette-smoking effect in the NHANES III population, both the decreases in FEV 1 /FVC and increases in 1 Ϫ FEV 3 /FVC for a given age group are striking (Fig 3) . Using either measurement, fractions progressively deteriorate with age relative to the never-smoking subjects. Consequently, by middle age current smokers have similar values to those of never-smokers who are about 20 years older (Fig 3) . In both our study ( instantaneous flow (ie, forced expiratory flows of 25%, 50%, 75%, or 85% of FVC) or average flow (FEF or FEF 75-85 ) over any given volume are necessarily dependent on both flow and volume measurements. As Miller et al 23, 27 point out, such flow measurements at differing volumes are inherently and necessarily variable.
The inherently high variability of FEF , in both never-smoker and current smoker groups, is confirmed in Figure 2 . The error of using 80% of the mean predicted value has been confirmed and emphasized by many authorities, 16 -20 and has been reconfirmed by our finding that approximately 25% of healthy never-smoking NHANES III adults have FEF values Ͻ 80% of the mean predicted value.
Even when 95% confidence limits for FEF 25-75 are used, there are an inordinate number of individuals with probable false-negative results (42%) who clearly have obstructive airways disease, especially among those who are Ͼ 60 years of age (Table 3) . Probable false-negative results for FEF measurements are also frequent in subjects with abnormally low FEV 3 /FVC values (ie, those with later expiratory obstruction or obstruction of long-timeconstant airways). On the other hand, apparent false-positive FEF values (Table 3) are found almost exclusively in younger adults. The fact that the LLN for FEF is an absolute rather than a relative value in all predicting equations is a factor in the high incidence of probable false-negative results.
There are several possible limitations in this study. Although the spirometric measurements followed ATS guidelines, 25 it is possible that some subjects gave incomplete historical details. While we do not have data for Asian individuals or other ethnic groups, the similarity of FEV 1 /FVC and FEV 3 /FVC values among thousands of white, black, and Latin adults in the United States, who differed considerably in height and nutritional status, suggests that the values given in Table 4 are likely to be universally valid. In clinical practice, we would express uncertainty when spirometric findings are equivocal, but purposely did not do so in this study. Rather, we distinguished normalcy from abnormality on purely statistical grounds, as have other authors. 27, 29 The use of a single-tailed LLN at the 95% confidence level in a healthy population causes approximately 5% of each measurement to be "abnormal," although the subject may not really be abnormal. Therefore, testing four parameters in 3,570 healthy subjects at the 5% level should result in approximately 714 abnormal values (3,570 ϫ 0.05 ϫ 4 ϭ 714). Lung restriction cannot be diagnosed definitively in this series in the absence of measurements that were not available on the NHANES III database, although Dykstra et al, 35 assessing patients with FEV 1 /FVC values of Ͻ 70%, found a relatively low incidence of reduced total lung capacity. Left ventricular failure with cardiomegaly can result in abnormal spirometry with combined restrictive and obstructive pattern. Thus, significant heart or other diseases, unknown to surveyors, might have been present. Although the FEV 6 has been suggested as a substitute for the FVC, 36 the FVC often exceeds the FEV 6 , especially with older age and smoking. Therefore, our analysis does not include FEV 1 /FEV 6 or FEV 3 /FEV 6 values. We did not investigate the role of the duration or intensity of cigarette smoking on spirometric values. We recommend that manufacturers replace the reporting of spirometric values as "a percent of predicted" with "mean predicted, and lower limit of normal." In addition, thoracic societies should consider the elimination of FEF and other forced expiratory flow values from reports, and their replacement with simpler, more valid, and easier to interpret FEV 3 /FVC values. 
